Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Review of Saccharomyces boulardii as a treatment option in IBD

17 May 2018

Abstract excerpt

CONTEXT: Review of the yeast Saccharomyces boulardii as a treatment option for the inflammatory bowel diseases (IBD) ulcerative colitis and Crohn's disease. OBJECTIVE: IBD is caused by an inappropriate immune response to gut microbiota. Treatment options could therefore be prebiotics, probiotics, antibiotics and/or fecal transplant. In this review, we have looked at the evidence for the yeast S. boulardii as a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clostridium difficile and Clostridium perfringens research
Share to Gut microbiota and health
Share to Inflammatory Bowel Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29771163
DOI: 10.1080/08923973.2018.1469143

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Review of Saccharomyces boulardii as a treatment option in IBDPMID 29771163Read ↗

Saccharomyces boulardii protects against murine experimental colitis by reshaping the gut microbiome and its metabolic profileSemantic proximity Read ↗

Saccharomyces boulardii Ameliorates Dextran Sulfate Sodium‐Induced Ulcerative Colitis in Mice by Regulating NF‐κB and Nrf2 Signaling PathwaysSemantic proximity Read ↗

Saccharomyces boulardii combined with triple therapy alter the microbiota in the eradication of Helicobacter pylori infectionSemantic proximity Read ↗

Saccharomyces boulardii: A Review of an Innovative Bio therapeutic AgentSemantic proximity Read ↗

Saccharomyces boulardii CNCM I-745 supplementation during and after antibiotic treatment positively influences the bacterial gut microbiotaSemantic proximity Read ↗

Choosing an appropriate probiotic product for your patient: An evidence-based practical guideSemantic proximity Read ↗

Saccharomyces boulardii decreases inflammation and intestinal colonization by Candida albicans in a mouse model of chemically-induced colitisSemantic proximity Read ↗

Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis &ndash; a reviewSemantic proximity Read ↗

Effect of Mutant and Engineered High-Acetate-Producing Saccharomyces cerevisiae var. boulardii Strains in Dextran Sodium Sulphate-Induced Colitis.Semantic proximity Read ↗

Investigating the Effect of Quadruple Therapy with Saccharomyces Boulardii or Lactobacillus Reuteri Strain (DSMZ 17648) Supplements on Eradication of Helicobacter Pylori and Treatments҆ Side Effects: A Double-Blind Placebo-Controlled Randomized Clinical TrialSemantic proximity Read ↗

Synergistic Effect of Postbiotic Yeast ABB C22® on Gut Inflammation, Barrier Function and Protection from Rotavirus InfectionSemantic proximity Read ↗

Synergistic effect of postbiotic yeast ABB C22® on gut in-flammation, barrier function and protection from Rotavirus in-fectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.